Εμφάνιση απλής εγγραφής

dc.creatorOlivry, T.en
dc.creatorSaridomichelakis, M.en
dc.date.accessioned2015-11-23T10:41:47Z
dc.date.available2015-11-23T10:41:47Z
dc.date.issued2013
dc.identifier10.1111/vde.12016
dc.identifier.issn9594493
dc.identifier.urihttp://hdl.handle.net/11615/31489
dc.description.abstractBackground: Anti-allergic drugs (e.g. antihistamines, glucocorticoids and ciclosporin) are often administered to dogs with atopic dermatitis to relieve pruritus and skin lesions. Allergen-specific intradermal tests (IDT) and allergen-specific IgE serological (ASIS) tests are used to characterize the allergens to which dogs are hypersensitive. Anti-allergic drugs have the potential to influence the results or interpretation of these tests. Objectives: To provide evidence-based recommendations for anti-allergic drug withdrawal times before IDT and ASIS tests. Methods: Three citation databases and abstracts from international meetings were searched for relevant studies. Studies were grouped based on similar interventions and types of tests. Withdrawal times for each type of drug and test were then extrapolated from the study results. Results: Before the assessment of immediate reactions to IDT, proposed optimal withdrawal times for antihistamines, oral glucocorticoids, topical/otic glucocorticoids and ciclosporin are 7, 14, 14 and 0 days, respectively. Studies have provided no evidence for drug withdrawal prior to ASIS tests for oral ciclosporin or prednisone/prednisolone. Owing to a lack of studies, recommendations for withdrawal times before ASIS tests cannot be made for topical glucocorticoids and antihistamines. Conclusions and clinical importance: These proposed withdrawal times are based on the existing evidence at the end of 2011. Care must be taken before extrapolating the suggested withdrawal times to other species, higher dosages, different formulations and/or durations of administration of tested drugs, as well as to other medications from the same category. © 2013 The Authors. Veterinary Dermatology. © 2013 ESVD and ACVD.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-84874760214&partnerID=40&md5=6f341603941ca6d07838c42af6d8094d
dc.subjectantiallergic agenten
dc.subjectimmunoglobulin Een
dc.subjectanimalen
dc.subjectanimal diseaseen
dc.subjectarticleen
dc.subjectblooden
dc.subjectdogen
dc.subjectdog diseaseen
dc.subjectevidence based medicineen
dc.subjectintracutaneous testen
dc.subjectserologyen
dc.subjectstandarden
dc.subjecttimeen
dc.subjectAnimalsen
dc.subjectAnti-Allergic Agentsen
dc.subjectDog Diseasesen
dc.subjectDogsen
dc.subjectEvidence-Based Medicineen
dc.subjectIntradermal Testsen
dc.subjectSerologic Testsen
dc.subjectTime Factorsen
dc.subjectCanis familiarisen
dc.titleEvidence-based guidelines for anti-allergic drug withdrawal times before allergen-specific intradermal and IgE serological tests in dogsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής